Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.2, replacing v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T18:30:30.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision tag updated from v3.2.0 to v3.3.1, a minor metadata change. No core content, study details, or outcomes were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T15:03:45.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the administrative banner about government funding lapse and operating status. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T07:43:02.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    No additions or deletions were detected between screenshots. The page content and layout appear unchanged, including the LOSVID study details.
    Difference
    0.4%
    Check dated 2025-11-03T01:24:00.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Update reflects a new version (v3.2.0) and a government-operating-status notice, replacing the previous v3.1.0 and guiding users to official status pages.
    Difference
    3%
    Check dated 2025-10-05T10:23:15.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Page updated to version v3.1.0 and removed multiple drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) with no new substantive content added.
    Difference
    0.3%
    Check dated 2025-09-28T03:17:46.000Z thumbnail image

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.